Articles

PP21 The light chain IgLV3-21 defines a new poor prognostic subgroup in Chronic Lymphocytic Leukemia: results from a multicenter study

BJH - 2018, issue Abstract Book BHS, february 2018

B. Stamatopoulos , T. Smith , E. Crompot , K. Pieters , R. Clifford , M. Mraz , P. Robbe , A. Burns , A. Timbs , D. Bruce , P. Hillmen , N. Meuleman MD, PhD, P. Mineur MD, R. Firescu , M. Maerevoet MD, V. De Wilde MD, PhD, A. Efira MD, J. Philippé MD, PhD, B. Verhasselt MD, PhD, F. Offner MD, PhD, A. Heger , D. Sims , H. Dreau , A. Schuh

Read more

O.6 Effect of bone marrow-mesenchymal stromal cell derived extracellular vesicles on survival, migration and chemoresistance of Chronic Lymphocytic Leukemia B-cells

BJH - volume 7, issue Abstract Book BHS, january 2016

E. Crompot , M. Van Damme , K. Pieters , N. Meuleman MD, PhD, D. Bron MD, PhD, P. Mineur MD, L. Lagneaux , B. Stamatopoulos

Read more

PP1.5 Epigenetics in chronic lymphocytic leukemia: significance of TET and IDH enzymes expression on prognosis and influence of microenvironment

BJH - volume 7, issue Abstract Book BHS, january 2016

M. Van Damme , E. Crompot , N. Meuleman MD, PhD, P. Mineur MD, D. Bron MD, PhD, L. Lagneaux , B. Stamatopoulos

Read more

P1.16 Monoclonal B-cell lymphocytosis (MBL): results olmpact of extracellular vesicles from mesenchymal stromal cells-based microenvironment on Chronic Lymphocytic Leukemia B-cells

BJH - volume 6, issue Abstract Book BHS, january 2015

E. Crompot , M. Van Damme , H. Duvillier , K. Pieters , P. Mineur MD, N. Meuleman MD, PhD, D. Bron MD, PhD, L.L. Lagneaux , B. Stamatopoulous

Read more

P1.17 DNA hydroxymethylation in chronic lymphocytic leukemia: TET and IDH mRNA expression, prognostic significance and influence of microenvironment

BJH - volume 6, issue Abstract Book BHS, january 2015

M. Van Damme , E. Crompot , N. Meuleman MD, PhD, P. Mineur MD, D. Bron MD, PhD, L. Lagneaux , B. Stamatopoulos

Read more

P2.01 Downregulation of cellular microRNA-150 is a new prognostic factor associated with a poor prognosis in Chronic Lymphocytic Leukemia patients

BJH - volume 5, issue Abstract Book BHS, january 2014

B. Stamatopoulos , N. Meuleman MD, PhD, E. Crompot , M. Van Damme , B. Dessars MD, PhD, H. El Housni , P. Mineur MD, D. Bron MD, PhD, L. Lagneaux

Read more

P2.05 Global HDAC enzymatic activity is a strong marker of poor prognosis in Chronic Lymphocytic Leukemia

BJH - volume 5, issue Abstract Book BHS, january 2014

M. Van Damme , E. Crompot , N. Meuleman MD, PhD, P. Mineur MD, B. Dessars MD, PhD, H. El Housni , D. Bron MD, PhD, L. Lagneaux , B. Stamatopoulos

Read more
X